Anti-IL-13R alpha 1 antibodies and their uses thereof

Details for Australian Patent Application No. 2007319605 (hide)

International Classifications

Event Publications

11 June 2009 PCT application entered the National Phase

PCT publication WO2008/060814 Priority application(s): WO2008/060814

18 June 2009 Amendment Made

The nature of the amendment is: Amend the invention title to read Anti-IL-13R alpha 1 antibodies and their uses thereof

28 January 2010 Alteration of Name

The name of the applicant has been altered to CSL Limited; Merck Sharp & Dohme Corp. 2008

16 September 2010 Assignment before Grant

CSL Limited; Merck Sharp & Dohme Corp. The application has been assigned to CSL Limited

17 February 2011 Application Accepted

Published as AU-B-2007319605

16 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.